Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Dougherty's Pharmacy, Inc. (MYDP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2021 |
REVOKED
| Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]: |
| 12/18/2020 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/30/2019 |
8-K
| Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, O... |
| 07/12/2019 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vo... |
| 05/23/2019 |
10-Q/A
| Quarterly Report for the period ended March 31, 2019 [amend] |
| 05/20/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
| 05/15/2019 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/08/2019 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/07/2019 |
3
| Womack Joshua (Director) has filed a Form 3 on Dougherty's Pharmacy, Inc. |
| 05/06/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 05/06/2019 |
3
| Edington Stewart (President and CEO) has filed a Form 3 on Dougherty's Pharmacy, Inc. |
| 05/06/2019 |
3
| FLYNN JOSEPH J (Director) has filed a Form 3 on Dougherty's Pharmacy, Inc. |
| 05/03/2019 |
4
| LEVECCHIO ANTHONY J (Director) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $0
Exercised 5,000 options to buy
@ $0
Bought 60,000 warrants
@ $0.2, valued at
$12k
|
|
| 05/03/2019 |
4
| CURETON WILL (Director) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $0
Exercised 5,000 options to buy
@ $0
Bought 60,000 warrants
@ $0.2, valued at
$12k
|
|
| 05/03/2019 |
4
| Phillips Troy (10% Owner) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $0
Bought 60,000 warrants
@ $0.2, valued at
$12k
|
|
| 05/03/2019 |
4
| LESLIE JAMES (CEO, Interim Pres., Int. CFO) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $0
Exercised 5,000 options to buy
@ $0
Bought 60,000 warrants
@ $0.2, valued at
$12k
|
|
| 04/29/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
| 04/22/2019 |
4
| Phillips Troy (10% Owner) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Bought 100,000 shares
@ $0.1725, valued at
$17.3k
|
|
| 04/11/2019 |
4
| Phillips Troy (10% Owner) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Bought 20,000 shares
@ $0.09, valued at
$1.8k
Bought 5,275 shares
@ $0.1149, valued at
$606.1
Bought 4,725 shares
@ $0.1149, valued at
$542.9
Bought 23,282 shares
@ $0.095, valued at
$2.2k
Bought 10,000 shares
@ $0.11, valued at
$1.1k
Bought 30,000 shares
@ $0.1, valued at
$3k
Bought 15,468 shares
@ $0.109, valued at
$1.7k
|
|
| 04/02/2019 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 02/07/2019 |
8-K
| Quarterly results |
| 11/15/2018 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/14/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
| 08/06/2018 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 07/31/2018 |
4
| LEVECCHIO ANTHONY J (Director) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,250 options to buy
@ $0 |
|
| 07/31/2018 |
4
| LESLIE JAMES (CEO, Interim Pres., Int. CFO) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,250 options to buy
@ $0 |
|
| 07/31/2018 |
4
| CURETON WILL (Director) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,250 options to buy
@ $0 |
|
| 06/15/2018 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits |
| 05/25/2018 |
4
| Heil Mark S (Former President and CFO) has filed a Form 4 on Dougherty's Pharmacy, Inc. |
| 05/25/2018 |
4
| LEVECCHIO ANTHONY J (Director) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,200 options to buy
@ $0 |
|
| 05/25/2018 |
4
| LESLIE JAMES (CEO, Interim Pres., Int. CFO) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,200 options to buy
@ $0 |
|
| 05/25/2018 |
4
| CURETON WILL (Director) has filed a Form 4 on Dougherty's Pharmacy, Inc.|
Txns:
| Exercised 5,200 options to buy
@ $0 |
|
| 05/22/2018 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Dougherty’ s Pharmacy, Inc. Announces Adjournment of Annual Meeting of Stockholders Dallas, Texas, May 22, 2018 – Dougherty’ s Pharmacy, Inc. or today announced that its 2018 Annual Meeting of Stockholders scheduled for May 16, 2018, was adjourned to achieve a quorum on the proposals to be approved. In order to provide additional time for the Company to obtain a quorum, the meeting date has been adjourned to June 12, 2018, at 1:30 PM, to be held at the Corporate Offices located at 5924 Royal Lane, Suite 250, Dallas, Texas, 75230. During the period of the adjournment, the Company will continue to solicit proxies from its stockholders with respect to the proposals set forth in the proxy statement. Only stockholders of record on the record date of April 13, 2018, will be entitled to and are ..." |
|
| 05/22/2018 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
|
|
|